Search NLS News

Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments.

The European Investment Bank (EIB) is lending EUR 20 million to BioLamina to expand its development of laminin technologies.

Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg.

The partnership will apply advanced AI capabilities to analyse complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient, the company states.

Pfizer and Valneva's Lyme disease vaccine candidate demonstrated strong efficacy in their Phase 3 VALOR trial.

Suturion has been named the winner of this year’s Medtech4Health Innovation Award, receiving SEK 100,000 for its surgical innovation SutureTOOL. At the same time, Nil Medical was honored with the Patient’s Prize for its invention Nil Medical Vestpack.

A global investigation led by journalists from the International Consortium of Investigative Journalists shows how Merck & Co has deployed a range of strategies to sustain high prices and stifle competition.

The industry members now include both a Dane, a Swede, a Norwegian and a Finn.

The research collaboration aims to develop a blood‑based test that measures naturally occurring antibodies against toxic amyloid‑β oligomers in healthy individuals, based on Alzinova’s Aβ42CC oligomer technology.

Anna Carbery's research looks at how we can implement AI-driven peptide design to make new cancer therapeutics.